Veterinarians Connect the (FDA-Approved) Prascend® Dots: Will Senior Horses Need to Change to the New Medication to Control Cushings and IR Symptoms?

Veterinarians Connect the (FDA-Approved) Prascend® Dots: Will Senior Horses Need to Change to the New Medication to Control Cushings and IR Symptoms?: The imminent release of Boehringer Ingelheim's FDA-approved Prascend to the equine market may mean serious changes are afoot for senior horses that are currently being treated with the compounded medication known as pergolide to control symptoms of equine Cushings disease (PPID) or insulin resistance.